First CRISPR clinical trial backed by U.S. companies launches

First CRISPR clinical trial backed by U.S. companies launches

Source: 
Stat
snippet: 

The first clinical trial of CRISPR-Cas9 sponsored by U.S. companies has launched, testing the genome-editing technique in patients with the blood disorder beta thalassemia, according to an announcement posted Friday on the U.S. clinical trials website.